Vascular Defect in Parkinson’s Disease

Significant vascular defect underlying the disease pathology in patients with moderately severe Parkinson’s disease has been found by a study.

Significant vascular defect underlying the disease pathology in patients with moderately severe Parkinson’s disease has been found by a study at the Georgetown University Medical Center, published in Neurology Genetics.

The study suggests that blood vessel walls called the blood-brain barrier (BBB), which normally acts as a crucial filter to protect the brain against toxins as well as allow passage of nutrients to nourish it, doesn’t work correctly in some Parkinson’s patients.

Parkinson’s Disease - Causes, Symptoms, Diagnosis, Treatment
Parkinson’s disease is a neurodegenerative disease caused by progressive dopamine brain cells loss. Symptoms of Parkinson’s disease are correctable to an extent.

‘Significant vascular defect underlying the disease pathology in patients with moderately severe Parkinson’s disease has been found by a study.’

BBB rather prohibits toxins from leaving the brain and inhibits nutrients such as glucose from entering. Perhaps even more damaging, the dysfunctional barrier allows inflammatory cells and molecules from the body to enter and damage the brain.

Drug Efficacy

This may help explain an earlier outcome of the same study, in which the drug nilotinib (repurposed leukemia drug) was able to halt motor and non-motor (cognition and quality of life) decline in the long term.

New Energy Mechanism for Fighting Parkinson�s Disease
Energy house of the cell inside brain cells uncovers a new recycling pathway that may help ward off Parkinson's disease.

The study randomized patients to 2 trials of either placebo or 150mgs or 300mgs nilotinib for 12 months (each trial with a washout before 2nd trial).

It was found that nilotinib was safe after 27 months, and patients who received nilotinib showed a dose-dependent increase of dopamine, the chemical lost as a result of neuronal destruction.

Death Rate from Parkinson�s Disease on the Rise
Death rate from Parkinson’s disease over the last two decades has risen to 63% in the United States.

This showed that nilotinib halted motor and non-motor decline in the patients taking the 300mgs higher dose, as published in Movement Disorders.

Vascular System and Parkinson’s disease

Nutritional Management of Parkinson's Disease
Parkinson's disease is a brain disorder which leads to many other related effects. Nutrition plays an important role in management of the disease.

The present study further examined the cerebrospinal fluid of patients via epigenomics.

“Not only does nilotinib flip on the brain’s garbage disposal system to eliminate bad toxic proteins, but it appears to also repair the blood-brain barrier to allow this toxic waste to leave the brain and to allow nutrients in. Parkinson’s disease is generally believed to involve mitochondrial or energy deficits that can be caused by environmental toxins or by toxic protein accumulation; it has never been identified as a vascular disease,” says the study’s senior author, Charbel Moussa, MBBS, Ph.D., director of the Medical Center’s Translational Neurotherapeutics Program.

The study for the first time shows that the body’s blood-brain barrier may serve as a potential target for the treatment for Parkinson’s disease and stirs further exploration into the brain’s vascular system.

Source-Medindia